Where to Buy Selank: Every Seller Is a Research Supplier

Summary: Five channels sell something called Selank and only one of them is straightforward about what it is. This page compares them on what you receive, what it costs and what can go wrong.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Where to buy selank has an unusual answer for anyone arriving from our GLP-1 coverage: there is no pharmacy channel at all. Not a difficult one, not an expensive one, not one that requires the right prescriber. It does not exist, and understanding why explains everything about the channels that remain.

The one we link sits below, and the comparison further down includes it rather than working around it.

Where readers actually buy it

Ascension Peptides — Selank

Research-grade Selank, tested by two outside labs and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off
Selank · 10 mg$47.50$23.75$2.38/mgGet the 10 mg →

The published certificate for lot 29-01260229 assays this vial at 12.29 mg against a 10 mg label, and reports no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

  • Batch certificates from two independent labs
  • Free shipping over $250
  • Ships same day if ordered before 2pm CST

What you are looking for, in one paragraph

Selank is a synthetic heptapeptide, seven residues in the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro, catalogued as PubChem CID 11765600 with the formula C33H57N11O9 and a molecular weight of 751.9 [4]. It is an analogue of tuftsin, an immune peptide whose sequence makes up its first four residues, extended with a Pro-Gly-Pro tail that slows enzymatic breakdown. It was developed in Russia and holds a Russian registration as an anxiolytic.

It is not a GLP-1 receptor agonist, has no effect on appetite or gastric emptying, and has no weight-loss indication in any jurisdiction. Readers find it through the same forums that discuss semaglutide, which is a fact about internet communities rather than about pharmacology. It is also worth being blunt that the evidence base is not remotely comparable: the incretins this site covers have large published randomized trials behind them, and Selank has a body of Russian-language clinical work that is hard to verify from outside plus a set of animal studies.

Why the pharmacy channel is closed

This is the part that surprises people, and the reasoning is worth following because it is the same reasoning that determines which channels can exist.

A compounding pharmacy operating under section 503A cannot simply make anything. To compound from a bulk substance that is not a component of an FDA-approved drug and has no USP monograph, the substance generally needs to appear on FDA's 503A bulks list, and FDA's interim policies sort nominated substances into three categories while that process runs [3].

Selank appears in none of them. Search the current category lists, updated May 14, 2026, and it is simply absent [2].

It was not always absent. FDA maintains a separate list headed "Bulk drug substances nominated but withdrawn", introduced as substances "previously in category 2 of the interim policies" that "were withdrawn by the nominators", and Selank acetate (TP-7) is on it [1]. So it was nominated, it sat in Category 2 for a period, and then the nomination was pulled.

The practical consequence is the same either way. No prescriber can write for it, no pharmacy can prepare it, and so every remaining channel is a non-medical one. That is a genuinely different situation from most of what this site covers, and closer to the one described in which channels can actually supply BPC-157.

The risk that follows the compound through every channel

Before comparing sellers, it helps to know what FDA actually objected to, because it is specific and it applies regardless of who ships the box.

FDA's stated concern is that "compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities", and that the agency "lacks important information regarding any safety issues raised by selank acetate administered to humans" [1].

Immunogenicity here means an immune response to the material itself. The two named drivers are aggregation, where peptide molecules clump into structures the immune system reads as foreign, and peptide-related impurities, the truncated or modified sequences left behind by synthesis. Both are consequences of how the material was made, purified and stored, which means the channel you buy through genuinely changes your exposure to them.

It also means two separate documents matter: a purity result, which tells you how much of the powder is the intended sequence, and an endotoxin or LAL result, which tells you about bacterial pyrogen load and is a completely different assay. Most of this market still does not publish the second one.

Where to buy selank: the five channels compared

ChannelWhat you actually receiveMain riskTypical cost
Domestic research-peptide supplierLyophilised powder in a sealed vial, labelled research use only, usually with a batch certificate you can open before payingDocumentation often stops at purity and identity; endotoxin testing varies batch to batch$47.50 list for 10 mg, $23.75 with a code, about $2.38/mg
Overseas marketplace listingOften the same class of powder, sometimes genuinely well made, shipped from Asia or eastern EuropeCustoms seizure, long uncontrolled transit, no practical refund path, certificates that are not lot-specific$10 to $30 per vial before shipping, plus the cost of a seized parcel
Grey-market reseller or forum contactRepackaged material from an upstream source you cannot identifyThe batch you receive is not the batch on any certificate shown; no recourse of any kindVaries, often below the domestic market
Nootropic retailer selling a nasal sprayA pre-mixed liquid in a spray bottle, marketed for human use in consumer packagingHuman-use marketing without approval; concentration and sterility usually undocumented; the format invites exactly the risk FDA named$30 to $60 per bottle
Compounding pharmacyNothing. It cannot lawfully be supplied this wayAny pharmacy offering it is operating outside the interim policiesNot applicable

The nasal spray row is the one that trips people up, because it looks like the most legitimate option. It is packaged like a consumer product, it names a dose, and it does not carry the awkward research-use label. That presentation is doing a lot of work. A spray marketed for human use has fewer legal grounds to stand on than a vial explicitly sold for laboratory work, and it is also the format where sterility matters most and is documented least. Our sibling page on the nasal spray format goes into what changes when the powder is already in solution.

Scoring the channel we link

We link Ascension Peptides on this page and earn a commission if you buy, disclosed on the card and in our disclaimer. Applying the comparison to it honestly means naming both halves.

What it does well: the certificate is lot-specific, tied to lot 29-01260229 with an analysis date of 2026-02-07, and issued by MZ Biolabs, a named laboratory in Tucson, Arizona with an address you can check. Purity is 99.32% by HPLC-UV with the chromatogram and peak list printed rather than summarised. Identity is confirmed by mass spectrometry, expected monoisotopic mass 751.43 Da against a measured 751.47 Da. The certificate also reports a measured 12.29 mg in a vial labelled 10 mg, which is an overfill and an unusual thing to publish. Stock is domestic, which removes the customs row entirely, and the listing carries no human-use claims.

What that document does not do: there is no endotoxin test, no LAL assay and no sterility screen anywhere on the February certificate. On the specific risk FDA named, that particular file does not answer.

There is a useful comparison available one batch across. The same vendor's June 2026 Selank batch, 29-05260628, has a certificate carrying a bacterial endotoxin test by kinetic chromogenic LAL to USP Chapter 85, reported under 0.20 EU/mL against a 0.5 EU/mL acceptance limit, alongside a rapid sterility screen and a heavy metals panel. The February certificate has none of them. So which testing you get is a batch question rather than a product question, and the scope widened across the catalogue in June. Read every certificate on the product page rather than only the one that is a clickable link, then ask which batch is being shipped.

Price across channels, briefly

At $23.75 with the code, the domestic vial is not the cheapest listing in the world and it is not far off. Overseas listings undercut it, sometimes substantially, and the saving is real right up until a parcel does not arrive and there is no mechanism to do anything about it. Quantity tiers of 3, 5 and 10 take 3%, 5% and 10% off the list price separately from the code, and free shipping starts at $250. The full breakdown, including what the assayed overfill does to the real per-milligram figure, sits on our Selank price page.

Questions people ask

Can I get Selank from a pharmacy with a prescription?
No. There is no FDA-approved Selank product to prescribe, and it appears on no current 503A category list, so a compounding pharmacy has no pathway to prepare it either. Any pharmacy offering it is operating outside FDA's interim policies.
Is buying Selank legal in the United States?
Selling and buying it as a research chemical is lawful. Selling it for human consumption is not, which is why legitimate suppliers label it for laboratory use only. Nothing on this page is a recommendation to use it.
Which channel has the best documentation?
Domestic research suppliers, comfortably. They are the only channel that routinely publishes lot-specific certificates you can open before paying. That is a low bar rather than a high one, and even with the best of them the endotoxin line depends on which batch you receive.
Why do overseas listings cost so much less?
Lower manufacturing and labour costs, no domestic warehousing, and no return infrastructure. The last of those is most of the difference. A cheaper vial that gets seized at the border or arrives after three weeks at ambient temperature was not actually cheaper.
Is the nasal spray a different compound?
It is usually the same peptide already dissolved in a carrier. What differs is the documentation and the legal posture: a spray marketed for human use is making a claim the vial does not, generally without publishing concentration, purity or sterility data.
How does this compare to buying a GLP-1?
It is not comparable. Semaglutide and tirzepatide have approved products, prescribers, pharmacies and a regulated supply chain. Even the unapproved research peptides we cover, such as [retatrutide without a prescription](/retatrutide/retatrutide-without-prescription/), have a published trial record behind them. Selank has neither the supply chain nor the trial record.

Where to buy selank narrows quickly once you accept that four of the five channels are variations on the same thing and the fifth does not exist. The real decision is not which channel but which document you insist on seeing, and the one worth insisting on is the certificate that names the batch actually being shipped to you.

References

  1. FDA, Certain Bulk Drug Substances for Use in Compounding May Present Significant Safety Risks, content current as of 04/22/2026
  2. FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, category lists updated May 14, 2026
  3. FDA, Compounding and the FDA: Questions and Answers
  4. PubChem Compound Summary for CID 11765600, Selank, National Library of Medicine